JP2021529746A5 - - Google Patents

Info

Publication number
JP2021529746A5
JP2021529746A5 JP2020572388A JP2020572388A JP2021529746A5 JP 2021529746 A5 JP2021529746 A5 JP 2021529746A5 JP 2020572388 A JP2020572388 A JP 2020572388A JP 2020572388 A JP2020572388 A JP 2020572388A JP 2021529746 A5 JP2021529746 A5 JP 2021529746A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
cycloalkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020572388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021529746A (ja
JP7610985B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/038908 external-priority patent/WO2020005888A1/en
Publication of JP2021529746A publication Critical patent/JP2021529746A/ja
Publication of JP2021529746A5 publication Critical patent/JP2021529746A5/ja
Application granted granted Critical
Publication of JP7610985B2 publication Critical patent/JP7610985B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020572388A 2018-06-26 2019-06-25 心臓サルコメア阻害剤 Active JP7610985B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862690249P 2018-06-26 2018-06-26
US62/690,249 2018-06-26
PCT/US2019/038908 WO2020005888A1 (en) 2018-06-26 2019-06-25 Cardiac sarcomere inhibitors

Publications (3)

Publication Number Publication Date
JP2021529746A JP2021529746A (ja) 2021-11-04
JP2021529746A5 true JP2021529746A5 (cg-RX-API-DMAC7.html) 2022-07-04
JP7610985B2 JP7610985B2 (ja) 2025-01-09

Family

ID=67211971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572388A Active JP7610985B2 (ja) 2018-06-26 2019-06-25 心臓サルコメア阻害剤

Country Status (4)

Country Link
US (1) US12187712B2 (cg-RX-API-DMAC7.html)
EP (1) EP3814343B1 (cg-RX-API-DMAC7.html)
JP (1) JP7610985B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020005888A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202006296YA (en) 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
EP3814343B1 (en) 2018-06-26 2023-01-11 Cytokinetics, Inc. Cardiac sarcomere inhibitors
JP7438148B2 (ja) * 2018-06-26 2024-02-26 サイトキネティックス, インコーポレイテッド 心臓サルコメア阻害剤
MA53491A (fr) 2018-08-31 2021-09-15 Cytokinetics Inc Inhibiteurs de sarcomes cardiaques
MX2022000498A (es) 2019-07-17 2022-02-03 Cytokinetics Inc Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihi dro-1h-inden-1-il) -2-metil-2h- tetrazol-5-carboxamida.
KR20230079053A (ko) 2020-08-28 2023-06-05 미요카디아, 인크. 미오신 조절제를 이용한 치료 방법
KR20240015622A (ko) 2021-03-04 2024-02-05 싸이토키네틱스, 인코포레이티드 심장 근절 억제제
TW202339760A (zh) * 2022-01-28 2023-10-16 韓商鐘根堂股份有限公司 用於預防或治療心臟衰竭(hf)之組合物
CN119789856A (zh) 2022-04-26 2025-04-08 迈奥卡迪亚公司 施用肌球蛋白抑制剂的方法
CA3268270A1 (en) * 2022-09-26 2024-04-04 Edgewise Therapeutics, Inc. 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND ASSOCIATED USES
JP7858148B1 (ja) 2023-03-27 2026-05-13 エッジワイズ セラピューティクス, インコーポレイテッド キナゾリンジオン化合物およびその使用
KR20250174911A (ko) 2023-03-27 2025-12-15 엣지와이즈 테라퓨틱스, 인크. 퀴놀리논 아미드 화합물 및 이의 용도
CN122070481A (zh) 2023-11-01 2026-05-19 百时美施贵宝公司 基于蛋白质水平用肌球蛋白抑制剂进行治疗的方法
WO2026143034A1 (en) * 2024-12-23 2026-07-02 Cytokinetics, Incorporated Fast skeletal muscle myosin inhibitors
CN122301864A (zh) * 2024-12-31 2026-06-30 广东东阳光药业股份有限公司 取代的茚类化合物及其用途

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
KR100477070B1 (ko) 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US5919785A (en) 1996-04-03 1999-07-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US20030158186A1 (en) 2001-12-21 2003-08-21 Fady Malik Compositions and methods for treating heart failure
US7399866B2 (en) 2003-01-14 2008-07-15 Cytokinetics, Inc. Compounds, compositions, and methods
JP2006516288A (ja) 2003-01-21 2006-06-29 アーケミックス コーポレイション 眼の薬物療法において有用なアプタマー治療薬
WO2004086865A1 (en) 2003-03-27 2004-10-14 Cytokinetics, Inc. Compounds, compositions and methods
RU2006101541A (ru) 2003-06-20 2006-06-10 Амген Инк. (US) Производные пиперазина и способ их применения
US7507735B2 (en) 2004-06-17 2009-03-24 Cytokinetics, Inc. Compounds, compositions and methods
US20060173183A1 (en) 2004-12-31 2006-08-03 Alantos Pharmaceuticals, Inc., Multicyclic bis-amide MMP inhibitors
TW200718692A (en) 2005-04-22 2007-05-16 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
WO2007078815A2 (en) 2005-12-16 2007-07-12 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
RU2318818C1 (ru) 2006-04-12 2008-03-10 Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
SA08290245B1 (ar) 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
US20090192168A1 (en) 2008-01-04 2009-07-30 Alex Muci Compounds, Compositions and Methods
US20110275673A1 (en) 2008-09-19 2011-11-10 Yibin Xiang Inhibitors of sphingosine kinase 1
ES2459468T3 (es) 2009-05-15 2014-05-09 Novartis Ag Arilpiridinas como inhibidores de aldosterona sintasa
US8592426B2 (en) 2011-01-24 2013-11-26 Hoffmann—La Roche Inc. Aryl-benzocycloalkyl amide derivatives
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2013048928A1 (en) 2011-09-27 2013-04-04 Bristol-Myers Squibb Company Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
TWI576347B (zh) 2012-01-20 2017-04-01 艾克泰聯製藥有限公司 作為p2x受體拮抗劑之雜環醯胺衍生物
US9199945B2 (en) 2013-06-21 2015-12-01 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
SMT202000071T1 (it) 2013-06-21 2020-03-13 Myokardia Inc Composti di pirimidinadione contro le condizioni cardiache
HRP20181109T1 (hr) 2013-12-11 2018-11-02 Biogen Ma Inc. Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji
US9663516B2 (en) 2014-12-18 2017-05-30 MyoKardia, Inc. Bicyclic-pyrimidinedione compounds
SG11201705928XA (en) 2015-01-22 2017-08-30 Myokardia Inc 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
US10501425B2 (en) 2015-10-02 2019-12-10 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
CN108430997B (zh) 2015-12-17 2021-06-04 先正达参股股份有限公司 杀微生物的噁二唑衍生物
US20190364899A1 (en) 2015-12-18 2019-12-05 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
CA3022432A1 (en) 2016-04-29 2017-11-02 Board Of Regents, The University Of Texas System Sigma receptor binders
EP3475275B1 (en) 2016-06-23 2024-04-10 Merck Sharp & Dohme LLC 3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
SI3519416T1 (sl) 2016-09-27 2021-08-31 Merck Sharp & Dohme Corp. Derivati kromana, izokromana in dihidroizobenzofurana kot mGluR2-negativni alosterični modulatorji, sestavki in njihova uporaba
WO2018089433A1 (en) 2016-11-08 2018-05-17 Navitor Pharmaceuticals, Inc. PHENYL mTORC INHIBITORS AND USES THEREOF
JP2020023442A (ja) 2016-12-19 2020-02-13 住友化学株式会社 オキサジアゾール化合物及び植物病害防除方法
US20200000822A1 (en) 2017-02-23 2020-01-02 Board Of Regents, The University Of Texas System Methods of treatment for cancer, sterol homeostasis, and neurological diseases
CN110325517B (zh) 2017-02-28 2021-03-02 南京明德新药研发有限公司 螺环类化合物及其应用
IL322175A (en) 2017-08-04 2025-09-01 Myokardia Inc Treatment of hypertrophic cardiomyopathy (HCM) with pyrimidinedione compounds
SG11202006296YA (en) 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
US10710994B2 (en) 2018-03-19 2020-07-14 Genentech, Inc. Oxadiazole transient receptor potential channel inhibitors
EP3814343B1 (en) 2018-06-26 2023-01-11 Cytokinetics, Inc. Cardiac sarcomere inhibitors
JP7438148B2 (ja) 2018-06-26 2024-02-26 サイトキネティックス, インコーポレイテッド 心臓サルコメア阻害剤
MA53491A (fr) 2018-08-31 2021-09-15 Cytokinetics Inc Inhibiteurs de sarcomes cardiaques
US10981905B2 (en) 2018-08-31 2021-04-20 Xenon Pharmaceuticals Inc. Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
MX2022000498A (es) 2019-07-17 2022-02-03 Cytokinetics Inc Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihi dro-1h-inden-1-il) -2-metil-2h- tetrazol-5-carboxamida.
LT3999180T (lt) 2019-07-17 2024-08-26 Cytokinetics, Inc. (r)-n-(5-(5-etil-1,2,4-oksadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-karboksamido polimorfai
WO2021011808A1 (en) 2019-07-17 2021-01-21 Cytokinetics, Inc. Cardiac sarcomere inhibitor oral formulations
KR20230079053A (ko) 2020-08-28 2023-06-05 미요카디아, 인크. 미오신 조절제를 이용한 치료 방법
KR20240015622A (ko) 2021-03-04 2024-02-05 싸이토키네틱스, 인코포레이티드 심장 근절 억제제
EP4370116B1 (en) 2021-07-16 2025-01-15 Cytokinetics, Inc. Aficamten dosage regimens for treating obstructive hypertrophic cardiomyopathy
US12077069B2 (en) 2021-08-06 2024-09-03 Dorel Juvenile Group, Inc. Child restraint
CN119789856A (zh) 2022-04-26 2025-04-08 迈奥卡迪亚公司 施用肌球蛋白抑制剂的方法

Similar Documents

Publication Publication Date Title
JP2021535164A5 (cg-RX-API-DMAC7.html)
JP2021529185A5 (cg-RX-API-DMAC7.html)
JP2024508526A5 (cg-RX-API-DMAC7.html)
JP2021511331A5 (cg-RX-API-DMAC7.html)
JP2002529532A5 (cg-RX-API-DMAC7.html)
JP2009535393A5 (cg-RX-API-DMAC7.html)
JP2023550444A5 (cg-RX-API-DMAC7.html)
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
JP2007511563A (ja) 新規チアゾリジン−4−オン誘導体
CA2681972A1 (en) Substituted dibenzoic acid derivatives and use thereof
US20210122761A1 (en) 1,3-di-substituted ketene compound and application thereof
RU2012109545A (ru) Использование лигандов ppar дельта для лечения или предотвращения воспалений или заболеваний, связанных с метаболизмом/выработкой энергии
RU2011123672A (ru) Гетероароматические соединения для применения в качестве hif ингибиторов
FR2562892A1 (fr) Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes
US6673923B2 (en) Pyrazole antimicrobial agents
JP2021513543A5 (cg-RX-API-DMAC7.html)
JP2024517769A5 (cg-RX-API-DMAC7.html)
JP2022542803A5 (cg-RX-API-DMAC7.html)
RU2008119465A (ru) Производные циклопропилуксусной кислоты и их применение
HU182461B (en) Process for producing new h-2 down-receptore antagonistic thiazole derivatives
JP2022544803A5 (cg-RX-API-DMAC7.html)
JP2007197324A (ja) 2,4,5−置換−1,3−アゾール誘導体
LU84797A1 (fr) Dihydropyridylimidates cycliques
WO2004000813A1 (ja) フェノキシピリジン誘導体又はその塩
HU191753B (en) Process for preparing 5-acyl-2-/1h/-pyridinine deriva-tives